My watch list
my.bionity.com  
Login  

Siemens plans to list Siemens Healthineers

01-Dec-2017

Siemens AG is preparing to list its separately managed healthcare unit on the Prime Standard segment of the Frankfurt Stock Exchange's Regulated Market. This move, which the company's Supervisory Board approved at its meeting today, is planned for the first half of 2018. "For Siemens Healthineers, the public listing is the next logical step and the foundation for expanding our strong position as a leading global supplier of healthcare technology," said Michael Sen, Chairman of the Siemens Healthineers Supervisory Board and the member of Siemens' Managing Board responsible, among other things, for healthcare technology.

"Frankfurt is one of the world's largest trading centers for securities, and its importance will continue to increase due to Brexit. As a highly liquid trading venue, Frankfurt is attractive for investors from around the world. The public listing will give Siemens Healthineers entrepreneurial flexibility and access to the capital market. The goal is to grow sustainably and profitably while actively shaping the paradigm shift in the healthcare industry," said Michael Sen.

For the public listing, Siemens Healthineers AG will be established. "Our preparations for the public listing are completely on schedule. The Strategy 2025 concept and the management team are in place. The legal prerequisites have largely been fulfilled. Deutsche Bank, Goldman Sachs International and J.P. Morgan have been engaged as global coordinators, and BNP PARIBAS, BofA Merrill Lynch, Citigroup and UBS Investment Bank as further syndicate banks," said Siemens Chief Financial Officer Ralf P. Thomas.

Facts, background information, dossiers
  • initial public offerings
More about Siemens
  • News

    Siemens and Biogen cooperate

    Siemens Healthineers and Biogen announced that the companies plan to jointly develop magnetic resonance imaging (MRI) applications with the intent of quantifying key markers of multiple sclerosis (MS) disease activity and progression. Siemens Healthineers aims to enable healthcare providers ... more

    Siemens expand its Walpole, Mass. Laboratory Diagnostic manufacturing facility

    Siemens Healthineers will invest around $300 million in its Walpole, Mass. laboratory diagnostics manufacturing and research and development facility. "The expansion of the Walpole facility fits into the strategic growth plans for the company and allows us to increase our manufacturing foot ... more

    Siemens acquires NEO New Oncology AG

    Siemens Healthineers has expanded its diagnostics portfolio with the acquisition of NEO New Oncology AG, Cologne, Germany. The company's cancer genome diagnostic platform NEO will support pathologists and oncologists with comprehensive molecular information to help select targeted cancer th ... more

  • Companies

    Siemens Healthcare Diagnostics Products GmbH

    Siemens Healthcare Diagnostics offers a broad portfolio of performance-driven diagnostics solutions that provide more effective ways to assist in the diagnosis, monitoring and management of disease. Our products and services offer the right balance of science, technology and practicality ac ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE